389,605 Shares in Cognex Corporation $CGNX Bought by Freestone Grove Partners LP

Freestone Grove Partners LP acquired a new position in shares of Cognex Corporation (NASDAQ:CGNX) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 389,605 shares of the scientific and technical instruments company’s stock, valued at approximately $28,215,000. Freestone Grove Partners LP owned 0.23% of Cognex as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Royal Bank of Canada raised its position in shares of Cognex by 13.2% during the 1st quarter. Royal Bank of Canada now owns 200,351 shares of the scientific and technical instruments company’s stock worth $5,976,000 after purchasing an additional 23,326 shares during the last quarter. Empowered Funds LLC acquired a new stake in Cognex in the 1st quarter worth about $291,000. Intech Investment Management LLC increased its stake in Cognex by 24.1% during the 1st quarter. Intech Investment Management LLC now owns 47,444 shares of the scientific and technical instruments company’s stock worth $1,415,000 after buying an additional 9,223 shares in the last quarter. Geneos Wealth Management Inc. increased its stake in Cognex by 402.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after buying an additional 736 shares in the last quarter. Finally, Cetera Investment Advisers raised its holdings in shares of Cognex by 7.5% during the second quarter. Cetera Investment Advisers now owns 13,208 shares of the scientific and technical instruments company’s stock valued at $419,000 after acquiring an additional 920 shares during the last quarter. 88.12% of the stock is owned by hedge funds and other institutional investors.

Cognex Price Performance

Shares of Cognex stock opened at $62.97 on Friday. The stock’s 50 day simple moving average is $64.54 and its 200-day simple moving average is $59.45. The stock has a market cap of $10.59 billion, a P/E ratio of 61.14 and a beta of 1.49. Cognex Corporation has a 1-year low of $34.60 and a 1-year high of $72.88.

Cognex (NASDAQ:CGNX) last posted its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.42 by $0.03. Cognex had a return on equity of 13.50% and a net margin of 16.05%.The firm had revenue of $291.26 million during the quarter, compared to analysts’ expectations of $292.10 million. During the same quarter last year, the firm earned $0.25 earnings per share. The business’s revenue for the quarter was up 16.9% on a year-over-year basis. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. As a group, research analysts expect that Cognex Corporation will post 1.68 EPS for the current fiscal year.

Cognex Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Thursday, August 20th will be paid a $0.085 dividend. The ex-dividend date of this dividend is Thursday, August 20th. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.5%. Cognex’s dividend payout ratio (DPR) is 33.01%.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. HSBC lowered Cognex from a “buy” rating to a “hold” rating and set a $65.00 price target on the stock. in a research note on Monday, August 10th. Seaport Research Partners set a $75.00 price objective on Cognex in a research note on Tuesday, May 26th. UBS Group set a $75.00 price objective on Cognex in a report on Tuesday, May 26th. Barclays reaffirmed an “overweight” rating and set a $80.00 target price (up from $75.00) on shares of Cognex in a research note on Monday, August 10th. Finally, Truist Financial upped their target price on shares of Cognex from $71.00 to $78.00 and gave the stock a “hold” rating in a report on Friday, August 7th. Two analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Cognex currently has a consensus rating of “Moderate Buy” and a consensus target price of $75.64.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.